Merrion, Novo Nordisk To Collaborate On Oral Insulin Analogues
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite giving up on inhaled insulin earlier this year, deal continues Novo Nordisk’s focus on enhancements to insulin formulation and delivery.
You may also be interested in...
Novo Signs Up Another Oral Insulin Partner, Hedging Its Bets
Novo Nordisk places another oral insulin technology bet with Emisphere; expands partnership with Merrion beyond insulin.
Novo Signs Up Another Oral Insulin Partner, Hedging Its Bets
Novo Nordisk places another oral insulin technology bet with Emisphere; expands partnership with Merrion beyond insulin.
MannKind Says Inhaled Insulin NDA On Track, Resumes Search For Partner
Afresa Phase III studies are complete, though FDA wants bioequivalence trial to support new inhaler device.